Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Chemed Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Chemed wird ein Gewinn- und Umsatzwachstum von 13.2% bzw. 6.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 12.8% pro Jahr wachsen soll.

Wichtige Informationen

13.1%

Wachstumsrate der Gewinne

12.6%

EPS-Wachstumsrate

Healthcare Gewinnwachstum17.3%
Wachstumsrate der Einnahmen6.8%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert21 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16
Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16
A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Is Chemed (NYSE:CHE) A Risky Investment?

Jun 29
Is Chemed (NYSE:CHE) A Risky Investment?

Chemed announces a five-year $550M amended and restated senior secured credit facility

Jun 29

Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)

Jun 14
Returns on Capital Paint A Bright Future For Chemed (NYSE:CHE)

Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

May 14
Estimating The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Gewinn- und Umsatzwachstumsprognosen

NYSE:CHE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20262,763N/AN/AN/A1
12/31/20252,594356N/AN/A3
12/31/20242,430313N/AN/A3
3/31/20242,293283302354N/A
12/31/20232,264273273330N/A
9/30/20232,225245259322N/A
6/30/20232,187226280345N/A
3/31/20232,165240208269N/A
12/31/20222,135250253310N/A
9/30/20222,129262220273N/A
6/30/20222,141277284334N/A
3/31/20222,142267249303N/A
12/31/20212,139269250309N/A
9/30/20212,132308271332N/A
6/30/20212,121303283344N/A
3/31/20212,091329450507N/A
12/31/20202,080319430489N/A
9/30/20202,069271410466N/A
6/30/20202,021263413470N/A
3/31/20201,992231258317N/A
12/31/20191,939220248301N/A
9/30/20191,874209238294N/A
6/30/20191,837201218275N/A
3/31/20191,806205241296N/A
12/31/20181,783206234287N/A
9/30/20181,753206152202N/A
6/30/20181,727190123183N/A
3/31/20181,70011391159N/A
12/31/20171,66798N/A162N/A
9/30/20171,64276N/A198N/A
6/30/20171,61767N/A162N/A
3/31/20171,592114N/A197N/A
12/31/20161,577109N/A135N/A
9/30/20161,572106N/A187N/A
6/30/20161,566108N/A175N/A
3/31/20161,557111N/A166N/A
12/31/20151,543110N/A172N/A
9/30/20151,524110N/A172N/A
6/30/20151,496106N/A135N/A
3/31/20151,475103N/A134N/A
12/31/20141,45699N/A110N/A
9/30/20141,42592N/A66N/A
6/30/20141,40885N/A111N/A
3/31/20141,40576N/A131N/A
12/31/20131,41377N/A151N/A
9/30/20131,43381N/A190N/A
6/30/20131,44784N/A162N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CHEDas prognostizierte Gewinnwachstum (13.2% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: CHEDie Erträge des Unternehmens (13.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14% pro Jahr).

Hohe Wachstumserträge: CHEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: CHEDie Einnahmen des Unternehmens (6.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.1% pro Jahr).

Hohe Wachstumseinnahmen: CHEDie Einnahmen des Unternehmens (6.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CHE in 3 Jahren voraussichtlich hoch sein wird


Wachstumsunternehmen entdecken